The company announced an investment in a new facility in Dundalk, County Louth, Ireland. On Jan. 26, 2017 Almac Group announced that as part of its ongoing global expansion, the company has secured a new facility in Dundalk, County Louth, Ireland. The new facility will be located at IDA Business Park. The new facility will increase the group’s European footprint by 32,000 ft2. The Dundalk facility will be utilized by Almac Pharma Services and Almac Clinical Services.
The company announced an investment in a new facility in Dundalk, County Louth, Ireland.
On Jan. 26, 2017 Almac Group announced that as part of its ongoing global expansion, the company has secured a new facility in Dundalk, County Louth, Ireland. The new facility will be located at IDA Business Park. The new facility will increase the group’s European footprint by 32,000 ft2. The Dundalk facility will be utilized by Almac Pharma Services and Almac Clinical Services.
In November 2016, the company announced expansion projects in Pennsylvania and Northern Ireland. Almac said it would invest £20-million (approximately $25.28-million) at its site in Souderton, PA to expand its existing 240,000-ft2 facility in addition to leasing a 26,000-ft2 office space in nearby Lansdale, PA. In Northern Ireland, Almac said it would invest around £5 million (approximately $6.32-million) in Craigavon to build an additional laboratory and office facility.
“Almac’s decision to expand into Dundalk provides the company with certainty of access to the European Union in the long term-this certainty of access is an increasingly important selling point for Ireland as we look to win business for Ireland,” Martin Shanahan, CEO, IDA Ireland said in a statement.
Source: Almac
Drug Solutions Podcast: Gliding Through the Ins and Outs of the Pharma Supply Chain
November 14th 2023In this episode of the Drug Solutions podcast, Jill Murphy, former editor, speaks with Bourji Mourad, partnership director at ThermoSafe, about the supply chain in the pharmaceutical industry, specifically related to packaging, pharma air freight, and the pressure on suppliers with post-COVID-19 changes on delivery.
Drug Solutions Podcast: Emerging Methods of Vaccine Administration and Distribution
June 20th 2023Michael Schrader, CEO and co-founder of Vaxess, discusses the latest on vaccine administration and different ways the pharmaceutical industry can distribute these products with Pharmaceutical Technology editor Jill Murphy.